21.95USD+1.29%Mkt Cap: 1.30B $P/E: —1d ago
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a …
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Pricier
1M Perf
Lower
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
Indicators:|
Key Statistics
Company
Market Cap1.30B $
Enterprise Value1.09B $
Revenue (TTM)283.30M $
Gross Profit170.94M $
Net Income (TTM)-12.78M $
Revenue/Share5.745 USD
Last Price21.95 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees943
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)46.07
PEG—
EV/EBITDA-406.66
EV/Revenue3.86
P/S4.61
P/B5.55
EPS (TTM)-0.23
EPS (Forward)0.48
52W Range
10.2870% of range26.92
52W High26.92 USD
52W Low10.28 USD
Profitability
Gross Margin65.69%
Oper. Margin-6.13%
EBITDA Margin-0.95%
Profit Margin-4.91%
ROE-5.56%
ROA-4.18%
Growth
Revenue Growth42.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.25M $
CapEx (TTM)5.83M $
FCF Margin5.93%
FCF Yield1.29%
Net Debt-211.76M $
Net Debt/EBITDA78.69
Balance Sheet
Debt/Equity0.00
Current Ratio3.92
Quick Ratio3.69
Book Value/Sh3.952 USD
Cash/Share3.562 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)22.92 USD
Upside (mean)+4.4%
Target Range15.00 USD – 30.00 USD
$15.00+4.4% to mean$30.00
# Analysts12
Ownership
Shares Out.59.45M
Float46.66M
Insiders2.19%
Institutions81.60%
Short Interest
Short Ratio7.9d
Short % Float13.37%
Short % Out.13.11%
Shares Short7.79M
Short (prev mo.)6.08M
Technical
SMA 5016.61 (+32.1%)
SMA 20017.13 (+28.1%)
Beta—
S&P 52W Chg20.05%
Avg Vol (30d)926.45K
Avg Vol (10d)1.23M
Technical Indicators
RSI (14)78.3
MACD1.1330
MACD Signal0.7539
MACD Hist.+0.3791
BB Upper21.27 USD
BB Middle18.36 USD
BB Lower15.45 USD
BB Width31.70%
ATR (14)0.9411 USD
Vol Ratio (20d)0.81x